跳至主要内容
临床试验/NCT02291042
NCT02291042已完成不适用

Pre-operative Administration of a Muscarinic Antagonist for Elective Cystoscopy Patients

Southern New Hampshire Medical Center0 个研究点目标入组 50 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
主要终点
Difference in mean bladder comfort (baseline at PACU admission to PACU discharge) between experimental and control groups

研究概览

简要总结

This study evaluates the ability of a belladonna and opium suppository given prior to surgery to improve bladder comfort after surgery for patients who are having elective ureteroscopy surgery.

详细描述

Belladonna and opium suppositories are administered postoperatively to relieve bladder discomfort usually caused by bladder spasms. The onset of action of the suppository is 30-60 minutes. Bladder spasms are more likely to occur following uteroscopy procedures. The spasms result in a felt desire to void, even when there is no urine in the bladder. The spasms can produce pain or a sense of severe urgency.

By administering a belladonna and opium suppository at the beginning of surgery, it is hoped that there will be a decrease in the incidence of bladder spasms, increased comfort and less need for additional medications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients from one urology practice schedule for elective uteroscopy.

排除标准

  • Patients with pre-operative indwelling catheter or urinary stent.
  • Patients who report any allergy to belladonna or opium.

研究组 & 干预措施

Suppository

Experimental

Patients will receive a single antispasmodic muscarinic suppository after induction of anesthesia but before insertion of urological scope for surgery. The suppository is composed of Belladonna (16.2 mg) and Opium (30 mg) in a water soluble base manufactured as Belladonna and Opium Supprettes.

干预措施: B+O Suppository (Drug)

结局指标

主要结局

Difference in mean bladder comfort (baseline at PACU admission to PACU discharge) between experimental and control groups

时间窗: Length of postoperative stay from admission to PACU to discharge from PACU an expected average of 2 hours

Bladder comfort is defined as bladder pain and bladder urgency. Bladder pain is measured on a 0-10 verbal analog scale with 0 = no pain and 10 = most pain possible. Bladder urgency is measured by a 0 - 4 scale with 0 = no desire to void, 1 = awarenes of need to void which can be delayed at least 30 minutes, 2 = moderate urgency than can be delayed for no more than 15 minutes, 3 = severe urgency that can be delayed for no more than 5 minutes, 4 = must void now. Pain and urgency are reported by the patient with or without questioning by the nurse.

次要结局

  • Duration of PACU length of stay(Time from admission to PACU to discharge from PACU an expected average of 2 hours)

研究者

发起方
Southern New Hampshire Medical Center
申办方类型
Other
责任方
Sponsor

相似试验